Cetuximab Market Size, Share, Challenges and Growth Analysis Report 2033 Cetuximab is a monoclonal antibody used to treat certain types of cancer, particularly colorectal cancer and head and neck cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which plays a crucial role in the growth and spread of cancer cells.
The cetuximab market is predicted to develop at a compound annual growth rate (CAGR) of x% from 2024 to 2034, when it is...
0 hisse senetleri
136 Views
0 önizleme